ClinicalTrials.Veeva

Menu

Detection of K14 in Bladder Cancer With a Non Invasive Technique

C

Corporacion Parc Tauli

Status

Terminated

Conditions

Bladder Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02027649
CIR2013 (Other Grant/Funding Number)
K14 in bladder cancer

Details and patient eligibility

About

By an invasive technique keratin 14 has been identified as a prognostic factor in bladder cancer. This study aims to analyze whether through a non-invasive technique keratin 14 can be used as a diagnostic and prognostic marker for this cancer.

Enrollment

400 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Bladder cancer

Exclusion criteria

  • Inability to sign the informed consent

Trial design

400 participants in 2 patient groups

Bladder cancer
Description:
Patients who suffered a bladder cancer
Control group
Description:
Patients with urologic diseases of non tumoral origin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems